What does this research mean for the field?

The nonprofit AI tool NoHarm is improving pharmacy practice in Brazil by reducing medication errors and has the potential to relieve pharmacist burden and improve patient safety globally. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This article explores how the NoHarm AI tool addresses medication errors in Brazilian pharmacies.

July 24, 2026Journal of Medical Internet Research0 citationsOpen Access

View Full Paper

First, Do NoHarm: How Pharmaceutical AI Is Improving Care Across Brazil

LTLuke Taylor

Key Points

This article explores how the NoHarm AI tool addresses medication errors in Brazilian pharmacies.
Describes the development and implementation of the NoHarm AI tool in Brazil.
Highlights the potential impact of NoHarm on medication safety across different health care settings.
Provides insights into the nonprofit model behind the AI intervention.
NoHarm tool aims to significantly reduce medication errors in pharmacies.
Improvements in patient safety outcomes are anticipated if implemented widely.
Potential benefits of the tool can extend beyond Brazil to global healthcare systems.

Abstract

Abstract Medication errors are a persistent challenge in health care across the world. In this News and Perspectives article, JMIR Correspondent Luke Taylor reports on NoHarm, a nonprofit AI tool changing pharmacy in Brazil, and its potential to relieve burden and improve patient safety elsewhere.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

First, Do NoHarm: How Pharmaceutical AI Is Improving Care Across Brazil

Key Points

Abstract

Cite This Study